H. Emrich | Semantic Scholar

The Pharmacology of Lysergic Acid Diethylamide: A Review

T. Passie, J. Halpern, D. Stichtenoth, H. Emrich, A. Hintzen
Psychology, Medicine
CNS neuroscience & therapeutics
1 December 2008

There is new interest in LSD as an experimental tool for elucidating neural mechanisms of (states of) consciousness and there are recently discovered treatment options with LSD in cluster headache and with the terminally ill.

View on Wiley

Psychotomimesis mediated by kappa opiate receptors

A. Pfeiffer, V. Brantl, A. Herz, H. Emrich
Psychology, Biology
Science
15 August 1986

In male subjects, the opiate-active (-)-isomer, but not the (+)- isomer, elicited dose-dependent dysphoric and psychotomimetic effects that were antagonized by naloxone, implying the existence of opposed opioid systems affecting emotional and perceptual experiences.

View on Publisher

The pharmacology of psilocybin

T. Passie, J. Seifert, U. Schneider, H. Emrich
Biology
Addiction biology
1 October 2002

All the available pharmacological data about psilocybin are presented and its still growing capacity for abuse and the widely dispersed data are presented.

View on Wiley

Discrepant target detection and action monitoring in obsessive–compulsive disorder

S. Johannes, B. Wieringa, D. Dietrich
Psychology, Biology
Psychiatry Research: Neuroimaging
30 November 2001

View on Elsevier

Elevated endogenous cannabinoids in schizophrenia.

F. Leweke, A. Giuffrida, U. Wurster, H. Emrich, D. Piomelli
Medicine, Psychology
Neuroreport
3 June 1999

Elevated anandamide and palmitylethanolamide levels in cerebrospinal fluid of schizophrenic patients may reflect an imbalance in endogenous cannabinoid signaling, which may contribute to the pathogenesis of schizophrenia.

View on PubMed

Towards a Cannabinoid Hypothesis of Schizophrenia: Cognitive Impairments Due to Dysregulation of the Endogenous Cannabinoid System

H. Emrich, F. Leweke, U. Schneider
Psychology, Medicine
Pharmacology Biochemistry and Behavior
1 April 1997

View on Elsevier

Comorbidity of alcohol and substance dependence with attention-deficit/hyperactivity disorder (ADHD).

M. Ohlmeier, K. Peters, U. Schneider
Medicine, Psychology
Alcohol and alcoholism
1 May 2008

It is revealed that habit-forming illnesses can be associated with a high comorbidity with ADHD, expressed in the form of alcohol abuse and also in consumption of illegal drugs.

View on PubMed

Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial.

K. Müller-Vahl, U. Schneider, H. Emrich
Medicine, Psychology
The Journal of clinical psychiatry
15 April 2003

The results provide more evidence that THC is effective and safe in the treatment of tics and hypothesized that the central cannabinoid receptor system might play a role in TS pathology.

View on PubMed

Prevalence of dissociative disorders among psychiatric inpatients in a German university clinic.

U. Gast, F. Rodewald, V. Nickel, H. Emrich
Psychology, Medicine
The Journal of nervous and mental disease
1 April 2001

A significant positive relationship was found between the severity of childhood trauma and dissociation, and dissociative disorders are common among German psychiatric inpatients.

View on PubMed

Neuronal correlates of ADHD in adults with evidence for compensation strategies – a functional MRI study with a Go/No-Go paradigm

W. Dillo, Andres Göke, M. Ohlmeier
Psychology, Biology
German medical science : GMS e-journal
19 April 2010

Functional magnetic resonance imaging during a Go/No-Go task seems to be an ideal tool for examining neuronal correlates of inhibitory control deficits in ADHD, and it is hypothesized that the enhanced activity is due to the ability of adult ADHD patients to compensate their deficits for a short time.

View PDF